10-epi-tazopsine

ID: ALA522195

PubChem CID: 25022686

Max Phase: Preclinical

Molecular Formula: C18H23NO6

Molecular Weight: 349.38

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: 10-Epi-Tazopsine | 10-epi-tazopsine|CHEMBL522195

Canonical SMILES:  COC1=C2[C@H]3NCC[C@]2(C[C@H](O)[C@@H]1O)c1c(ccc(OC)c1O)[C@@H]3O

Standard InChI:  InChI=1S/C18H23NO6/c1-24-10-4-3-8-11(16(10)23)18-5-6-19-13(14(8)21)12(18)17(25-2)15(22)9(20)7-18/h3-4,9,13-15,19-23H,5-7H2,1-2H3/t9-,13+,14-,15-,18-/m0/s1

Standard InChI Key:  CQFMGBHPLGTYRE-ANUCULNSSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   11.3152  -11.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3141  -11.8607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7425  -11.0297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0271  -10.6205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3129  -13.5046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3107  -14.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0232  -14.7426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7396  -14.3315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0274  -13.0926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7435  -13.5039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4537  -13.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4541  -12.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7381  -11.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0216  -12.2691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7375  -12.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1625  -13.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1583  -12.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5946  -14.7357    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.0199  -15.5676    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6007  -10.6210    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5993  -12.2727    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6005   -9.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4458  -13.9125    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   13.4526  -14.7466    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4496  -15.5716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1682  -11.8534    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  9 14  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
  1  2  2  0
  9 15  1  6
  5  6  1  0
 11 16  1  0
  6  7  1  0
 16 17  1  0
 15 17  1  0
  7  8  1  0
  6 18  1  1
  8 10  2  0
  7 19  1  1
  9 10  1  0
  1 20  1  0
  3  4  2  0
  2 21  1  0
  4  1  1  0
 20 22  1  0
  9  5  1  0
 11 23  1  1
  2 14  1  0
  8 24  1  0
 24 25  1  0
 13  3  1  0
 12 26  1  6
M  END

Alternative Forms

  1. Parent:

Associated Targets(non-human)

Plasmodium yoelii yoelii (73 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 349.38Molecular Weight (Monoisotopic): 349.1525AlogP: 0.07#Rotatable Bonds: 2
Polar Surface Area: 111.41Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 9.57CX Basic pKa: 8.19CX LogP: -1.48CX LogD: -2.18
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.51Np Likeness Score: 1.91

References

1. Carraz M, Jossang A, Rasoanaivo P, Mazier D, Frappier F..  (2008)  Isolation and antimalarial activity of new morphinan alkaloids on Plasmodium yoelii liver stage.,  16  (11): [PMID:18456502] [10.1016/j.bmc.2008.04.033]

Source